| Literature DB >> 25506425 |
Abdulkadir Bedirli1, Bulent Salman1, Osman Yuksel1.
Abstract
Background. The present study aimed to compare the clinical outcomes of laparoscopic versus open surgery for colorectal cancers. Materials and Methods. The medical records from a total of 163 patients who underwent surgery for colorectal cancers were retrospectively analyzed. Patient's demographic data, operative details and postoperative early outcomes, outpatient follow-up, pathologic results, and stages of the cancer were reviewed from the database. Results. The patients who underwent laparoscopic surgery showed significant advantages due to the minimally invasive nature of the surgery compared with those who underwent open surgery, namely, less blood loss, faster postoperative recovery, and shorter postoperative hospital stay (P < 0.05). However, laparoscopic surgery for colorectal cancer resulted in a longer operative time compared with open surgery (P < 0.05). There were no statistically significant differences between groups for medical complications (P > 0.05). Open surgery resulted in more incisional infections and postoperative ileus compared with laparoscopic surgery (P < 0.05). There were no differences in the pathologic parameters between two groups (P < 0.05). Conclusions. These findings indicated that laparoscopic surgery for colorectal cancer had the clear advantages of a minimally invasive surgery and relative disadvantage with longer surgery time and exhibited similar pathologic parameters compared with open surgery.Entities:
Year: 2014 PMID: 25506425 PMCID: PMC4259079 DOI: 10.1155/2014/530314
Source DB: PubMed Journal: Minim Invasive Surg ISSN: 2090-1445
Patient and tumor characteristics.
| LCRS group | OCRS group |
| |
|---|---|---|---|
| Age (y), mean ± SD | 57.7 ± 9.2 | 62.3 ± 11.1 | NS |
| Gender (male/female) | 38/27 | 56/42 | NS |
| ASA (%) | NS | ||
| I | 16 (25) | 22 (22) | |
| II | 29 (44) | 45 (46) | |
| III | 20 (31) | 31 (32) | |
| Tumor distribution (%) | NS | ||
| Right colon | 17 (26) | 31 (32) | |
| Left colon | 6 (9) | 7 (7) | |
| Sigmoid colon | 13 (20) | 24 (24) | |
| Rectum | 29 (45) | 36 (37) | |
| Operation (%) | NS | ||
| Right hemicolectomy | 17 (26) | 31 (32) | |
| Left hemicolectomy | 6 (9) | 7 (7) | |
| Sigmoid resection | 11 (17) | 10 (10) | |
| Anterior resection | 9 (14) | 21 (21) | |
| Low anterior resection | 22 (34) | 29 (30) | |
| Protective ileostomy: yes (%) | 19 (29) | 23 (23) | NS |
| Neoadjuvant chemoradiotherapy: yes (%) | 17 (26) | 22 (22) | NS |
NS: not significant. ASA: American Society of Anesthesiologist.
*Chi-square test.
Operative and postoperative results of the two patient groups.
| LCRS group | OCRS group |
| |
|---|---|---|---|
| Operation time (min), mean ± SD | 216 ± 53 | 172 ± 48 | 0.039† |
| Operative blood loss (mL), mean ± SD | 140 ± 35 | 220 ± 45 | 0.040† |
| Time to flatus (d), mean ± SD | 1.6 ± 1.4 | 2.3 ± 1.7 | 0.014† |
| Time to liquid diet (d), mean ± SD | 2.3 ± 1.9 | 2.9 ± 2.3 | 0.032† |
| Time to normal diet (d), mean ± SD | 3.4 ± 2.2 | 4.2 ± 2.8 | 0.030† |
| Stay in ICU (d), mean ± SD | 2.3 ± 2.7 | 2.4 ± 4.4 | NS |
| Total hospital stay (d), mean ± SD | 4.5 ± 4.0 | 6.2 ± 5.3 | 0.028† |
NS: not significant. ICU: intensive care unit.
†Student's t-test.
Postoperative morbidity and mortality.
| LCRS group | OCRS group |
| |
|---|---|---|---|
| Incision infection | 1 (2) | 9 (9) | 0.021† |
| Anastomotic leakage | 2 (3) | 3 (3) | NS |
| Postoperative ileus | 2 (3) | 5 (5) | 0.021† |
| Major medical complication (%) | NS | ||
| Pneumonia | 3 (5) | 3 (3) | |
| Cardiac decompensation | 1 (2) | — | |
| Myocardial infarction | 1 (2) | 1 (1) | |
| Renal failure | — | 1 (1) | |
| Cerebrovascular accident | — | 1 (1) | |
| Death in hospital | — | 1 (1) | NS |
NS: not significant.
†Student's t-test.
Comparison of the pathological parameters in two groups.
| LCRS group | OCRS group |
| |
|---|---|---|---|
| Number of lymph nodes, mean ± SD | 19 ± 7 | 23 ± 8 | NS |
| Histology (%) | NS | ||
| Well-differentiated adenocarcinoma | 16 (25) | 20 (20) | |
| Moderately differentiated adenocarcinoma | 29 (45) | 41 (42) | |
| Poorly differentiated adenocarcinoma | 17 (26) | 31 (32) | |
| Others | 3 (4) | 6 (6) | |
| Tumor stage (TNM) (%) | NS | ||
| I | 7 (11) | 7 (7) | |
| II-A | 14 (21) | 17 (17) | |
| II-B | 17 (26) | 27 (28) | |
| III-A | 9 (14) | 19 (20) | |
| III-B | 11 (17) | 16 (16) | |
| III-C | 7 (11) | 12 (12) |
NS: not significant.